✦ LIBER ✦
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease
✍ Scribed by L. S. Kiss; T. Szamosi; T. Molnar; P. Miheller; L. Lakatos; A. Vincze; K. Palatka; Z. Barta; B. Gasztonyi; A. Salamon; G. Horvath; G. T. Tóth; K. Farkas; J. Banai; Z. Tulassay; F. Nagy; M. Szenes; G. Veres; B. D. Lovasz; Z. Vegh; P. A. Golovics; M. Szathmari; M. Papp; P. L. Lakatos; for the Hungarian IBD Study Group
- Book ID
- 108606445
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 191 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.